[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
October 2, 2002

Advisory on Clinical Holds

Author Affiliations

Not Available

Not Available

JAMA. 2002;288(13):1579. doi:10.1001/jama.288.13.1579-JFD20010-4-1

The FDA has posted information on the Internet about the use of its authority in instances when it appears that a clinical investigator's misconduct poses ongoing risk to the safety and welfare of human subjects in a study involving human drug or biological products. For full text, see http://www.fda.gov/cber/guidelines.htm.

First Page Preview View Large
First page PDF preview
First page PDF preview